Short term effect of Lucentis (Ranibizumab) as pretreatment to laser photocoagulation versus Lucentis (Ranibizumab) combined with laser photocoagulation in the treatment of diabetic macular edema. A prospective, randomized study.
Phase of Trial: Phase III
Latest Information Update: 25 Jun 2011
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 25 Jun 2011 New trial record